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Introduction:  The 2004 World Health Organization Classification of Renal Neoplasms defined epithelioid
angiomyolipoma as a potentially malignant mesenchymal neoplasm, characterized by a proliferation of
predominantly epithelioid cells with approximately one third of patients experiencing metastases and one
half of them having a history of tuberous sclerosis complex.
Observations:  We report two cases of renal epithelioid angiomyolipoma diagnosed at our institution in
order to analyze their clinical behaviour and histopathological features, and insist on diagnostic pitfalls.
Conclusion:  Renal tumours with certain unusual features should be investigated immunohistochemically to
exclude the possibility of epithelioid angiomyolipoma. These tumours are more likely to have an aggressive
behaviour when they show more morphologic features predicting malignancy.
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ntroduction
lassic renal angiomyolipoma (AML) is a benign mesenchymal
umour containing fat, smooth-muscle cells and thick-walled blood-
essels. The epithelioid morphologic variant is defined by the 2004
orld Health Organization (WHO) Classification of Renal Neo-
lasms as a potentially malignant neoplasm, characterized by a
roliferation of predominantly epithelioid cells with approximately
ne third of patients experiencing metastases [1]. Epithelioid-AML
EAML) is included in the family of perivascular epitheloid cell
umour (PECT) which is associated genetically with tuberous scle-

















































 28-year-old-woman having a history of TSC and bilateral dull
umbar pain was hospitalized with haematuria and acute left lum-
ar pain. Physical examination revealed bilateral lumbar masses.
he woman then presented internal bleeding and acute severe
naemia (5 g/dl) resistant to reanimation and transfusion. Computed
omography (CT) showed bilateral renal heterogeneous masses.
he biggest mass was involving nearly the whole left kidney
Fig. 1a). It was complicated by an intra tumoral and retroperitoneal
aemorrhage. A radical left nephrectomy was performed immedi-
tely. Macroscopically, the tumour was yellowish non-encapsulated
Fig. 1b) measuring 16 cm ×  9 cm ×  7 cm and comprising areas of
aemorrhage with a ruptured subcapsular haematoma. Histopatho-
ogically, the tumour was composed of epithelioid cells in sheet
attern (>80% of tumour size). These cells had often enlarged
leomorphic nuclei and abundant eosinophilic cytoplasm. Scat-





igure  1  (case 1) (a) CT scan: multiple heterogeneous masses of both ki
o the retro peritoneum (b) Gross appearance in EAML: a lobulated white y
ushes to the periphery the normal renal parenchyma (pink arrows). (c) Histo
haematoxylin and eosin, original magnification 20×). (d) Histologic featur
haematoxylin and eosin, original magnification 40×).O. Boudaouara et al.
Fig. 1c and d). A perinephric fat infiltration was identified but
either necrosis nor renal vein invasion were seen. Immunohisto-
hemically, Human Melanoma Black 45 (HMB45) was diffusely
mmuno-positive. The diagnosis of EAML was made. After a 4-
onth follow-up, no metastases were detected. A right renal AML
mbolization was planned subsequently.
econd  case
 56-year-old-man, known carrying a right renal AML diagnosed
n ultrasonography 12 years ago, underwent evaluation for recent
ight dull lumbar pain. Physical examination revealed a right lumbar
ass. A control ultrasonography showed an increased-size mid-
olar hyperechogenous mass concomitant with the genesis of a
ew low-polar heterogeneous mass both involving the right kid-
ey. CT concluded to a suspicious low-polar tumour (Fig. 2a).
o evidence of TSC or tumours in other locations was found.
 radical right nephrectomy was performed. Macroscopically,
wo encapsulated tumours were identified. The first was browneasuring 7 cm ×  6 cm ×  5 cm, while the second was yellowish
easuring 5 cm ×  5 cm ×  4.5 cm (Fig. 2b). Histopathologically, the
rst tumour was a classic AML whereas the second showed similar
istologic findings (Fig. 2c) as the first case’s tumour except necro-
dneys with an intra-tumoral haemorrhage in the left kidney extending
ellowish tumour (green star) with areas of haemorrhage. The tumour
logic features of EAML: mature fat (red stars) and smooth muscle cells
es of EAML: Epithelioid cells with abundant eosinophilic cytoplasm
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Figure  2  (case 2) (a) CT scan: an hypodense mass of 5.3 cm in the lower pole of the right kidney (pink arrows). (b) Gross appearance: the first
tumour (yellow star): a brown lobulated encapsulated mass, the second tumour (red star): a white yellowish mass (c) Histologic findings in EAML
















cells (yellow arrows) were often seen (haematoxylin and eosin, origin
(original magnification 40×).
sis which was observed in this case. Immunohistochemically, both
tumours showed HMB45 diffuse positivity (Fig. 2d). Two AMLs
were diagnosed: a classic one and an epithelioid one. The patient
was lost of sight within 6-month follow-up with no metastasis objec-
tified.
Discussion
PECT represent a family of tumours including classic AML and
clear epithelioid cell tumours reported under a variety of names
such as EAML and clear cell sugar tumour [3]. The WHO has
recently introduced this unifying term of “PECT” and defined it as
“a mesenchymal tumour composed of histologically and immuno-
histochemically distinctive perivascular epitheloid cells [1].”
There is a strong association between PECT and genetic alterations
of TSC, an autosomal dominant genetic disease due to loss of het-
erozygosity in the TSC1 region (9q34) or TSC2 region (16p) [2,3].
In fact, nearly one half of patients diagnosed with AML have a his-





gnification 40×). (d) Immunostain for HMB45 in renal tumour cells
iscovered incidentally on imaging due to the presence of fat in
hem. Owing to their indolent behaviour, they are rarely resected or
mbolized until they reach a size where the possibility of haemor-
hage is significant as happened in our first case.
lassic AMLs represent 1% of surgically removed renal tumours
1], while EAMLs are extremely rare accounting for 4.6% of con-
ecutively resected AMLs [5].
AML’s mean age is 40 years with an even sex predisposition. No
pecific features of EAML in terms of clinical manifestations or
maging modalities comparing to classic AML have been found.
rossly, these tumours are solid often haemorrhagic. Microscopi-
ally, EAML had two architectural patterns: AML with carcinoma
ike growth pattern characterized by large cells arranged in cohesive
ests, and AML with epithelioid spindled cells organized in diffuse
rowth pattern [2]. In 2004 WHO considered AML as epithelioid
hen epithelial morphology is predominant [1]. In our two cases,
he epithelioid component represents more than 80% of the tumour


































































[9] Brimo F, Robinson B, Guo C, Zhou M, Latour M, Epstein JI. Renal
epithelioid angiomyolipoma with atypia: a series of 40 cases with empha-00 
inoma or melanoma, particularly when epithelioid component and
uclear atypia are evident.
ML shows strong immunostaining by melanocytic marker
HMB45, melan-A) and smooth muscle actin (SMA) but neither
pithelial markers nor S-100 protein were immunopositive.
adical tumour resection could be important in the treatment. Adju-
ant radiochemotherapy may be beneficial, but their effects need
urther investigation.
ecurrence was seen in around 17% of patients and metastasis in
bout 30% of patients [6]. The commonest metastatic sites were
ymph nodes, liver, lung and peritoneum. The meantime to metas-
ases in patients developing metastatic disease during follow-up is
7–31 months [2]. The prognostic factors predicting malignancy in
AML are not well-defined. They include associated TSC, tumour
ize (>7.7 cm), extrarenal extension or renal vein invasion, carci-
oma like growth pattern, tumour necrosis, percentage of atypical
pithelioid cells ≥70%, >2 mitotic figures/10HPF and atypical
itoses [5,7–9]. The frequency of these adverse prognostic parame-
ers was correlated with disease progression. In our two cases, none
howed evidence of malignant clinical behaviour at the available
ollow-up period although they contained, each, six of the above-
entioned criteria; therefore, the diagnosis of malignancy should
e made only on the basis of the presence of metastases. P53 gene
utation, detected in EAML but not classic AML, is suggested to
ave a role in the malignant nature of EAML [1].
onclusion
AMLs have significant overlap in morphology with more com-
only occurring renal neoplasms. Appropriate diagnosis requires
dequate immuno-staining with melanocytic makers. EAML can
ehave aggressively and even metastasize. Disease progression
eems to be correlated with the number of poor prognosis’s param-
ters encountered. Surgical resection alone may not be sufficient
nd adjuvant therapy may be needed. A multimodality treatment
pproach needs to be explored in order to settle a standardized
herapy for this newly recognized variant of AML.
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